We provide real estate investors with advisory, acquisition, debt & structured finance, valuation, property management, leasing, and disposition services for the full spectrum of life sciences facilities. CBRE’s expertise spans many life sciences categories and property types and leads the industry in managing highly-regulated space.
Clients such as pharmaceutical, biotech, medical device and genomics, as well as contract research organizations (CROs) and contract manufacturing organizations (CMOs), rely on CBRE for their real estate services.
Related Insights
-
Brief | Intelligent Investment
Venture Capital Targets Early-Stage Life Sciences Companies; IPOs Increase for Late-Stage Enterprises
October 3, 2023
While annual venture capital (VC) funding for life sciences companies has tapered off since reaching a record high in 2021, early-stage enterprises are receiving their biggest share ever.
-
CBRE’s Life Sciences (LS) Sector recently hosted a FOCUS Forum on “Disruptors in the Lab.” 15 clients and CBRE colleagues collaborated during the virtual event which highlighted expert insights from various organizations and brought together innovators who are reshaping the laboratory landscape.
-
Five actions that can make a sustainable difference in the lab.
Recent Press
-
Press Release
U.S. Life Sciences Real Estate Market Slows to More Sustainable Pace in Q2
July 27, 2023
Lab vacancy rises, but employment continues to grow; Philadelphia, Washington, DC, among markets registering increases in demand
-
Full Spectrum Lab Services from CBRE offers extensive capabilities across industries
-
Press Release
U.S. Life Sciences Real Estate Market Normalized in Q4 After Robust Growth of Previous Two Years
January 27, 2023
New supply of life sciences real estate outpaced demand in many top U.S. life sciences markets in the fourth quarter, boosting the sector’s vacancy rate back toward pre-pandemic levels, according to a new report from CBRE.
Search CBRE Life Sciences career opportunities
Leadership
Life Sciences Occupier Services
Real estate to create better outcomes for your life sciences business.
Core Values of our Solutions
We understand the critical nature of your portfolio and prioritize quality, compliance, health, and safety in everything we do.- Quality & Compliance: CBRE always keeps client's inspection-ready through client quality teams, a global network of life sciences quality experts, and standardized GxP compliant processes and technologies.
- Health & Safety: We know the complexities of life sciences research and manufacturing and rely on a strong safety program to assure our people operate safely, and our clients and visitors work in safe and healthy environments.
CBRE Enhances Integrated Laboratory Solutions Capabilities with Acquisition of Full Spectrum Group
Related Insights
Chromatography data systems (CDS) play a crucial role in the lab, generating accurate and reliable data in various scientific fields. Read more in this article published in Lab Manager by Full Spectrum's Roger Reeve.
CBRE’s Life Sciences (LS) Sector recently hosted a FOCUS Forum on “Disruptors in the Lab.” 15 clients and CBRE colleagues collaborated during the virtual event ...
Five actions that can make a sustainable difference in the lab.
Amid unprecedented growth for the life sciences sector, this report identifies the top 25 markets for life sciences research talent.
Leadership
Life Sciences Investor Services
Find your next life sciences investment
Real estate solutions down to a science
Comprehensive Investor Services
2023 U.S. Life Sciences Outlook
Leadership
- Americas Life Sciences Leader, Advisory
Matthew Gardner
Americas Life Sciences Leader, Advisory, CBRE
Featured Insights
-
Brief | Intelligent Investment
Venture Capital Targets Early-Stage Life Sciences Companies; IPOs Increase for Late-Stage Enterprises
October 3, 2023
While annual venture capital (VC) funding for life sciences companies has tapered off since reaching a record high in 2021, early-stage enterprises are receiving their biggest share ever.
-
CBRE’s Life Sciences (LS) Sector recently hosted a FOCUS Forum on “Disruptors in the Lab.” 15 clients and CBRE colleagues collaborated during the virtual event which highlighted expert insights from various organizations and brought together innovators who are reshaping the laboratory landscape.
-
Five actions that can make a sustainable difference in the lab.
-
Amid unprecedented growth for the life sciences sector, this report identifies the top 25 markets for life sciences research talent.
-
A convergence of breakthroughs in biological sciences, automation, technology and workplace wellbeing is driving change in laboratory design.
-
The U.S. life sciences industry has returned to a more normal pace at the start of 2023.
-
For life sciences companies, enabling smarter procurement and embracing innovation are two keys to facing the future with confidence.
-
Article
Integrated lab and extended reality solutions: the augmented future of lab asset management with CBRE
February 21, 2023
CBRE has pioneered the use of direct collaboration with original equipment manufacturers (OEMs) and on-site troubleshooting, driving forwards faster installation of systems, reducing downtime, and delivering higher productivity for clients.
-
CBRE’s Life Sciences (LS) Sector recently hosted a FOCUS Forum, a virtual event where experts from CBRE and client organizations shared cost saving strategies and best practices amid rampant inflation. Panelists addressed topics such as construction costs, operational changes, wage increases, supply chain issues and capital reallocation.
-
Life Sciences see increase in flexible office space and new demand for flexible labs.
-
CBRE’s Life Sciences Integrated Lab Solutions Sector recently hosted a FOCUS Forum, “Is Your Lab Driving Better Science?” Clients and CBRE professionals attended the virtual event, where experts shared best practices and solutions to improve efficiency and effectiveness of laboratory environments.
-
Brief | Intelligent Investment
Lab/R&D Space Market Remains Strong Despite H1 2022 Drop in Life Sciences Funding
August 3, 2022
After peaking in 2021, life sciences funding has plunged this year due to market uncertainty.
-
Article | Creating Resilience
Sustainability Leadership: How Life Sciences Companies Are Evolving to Meet Green Targets
July 26, 2022
CBRE’s Life Sciences Sector hosted a FOCUS Forum on “Sustainability Leadership: How life sciences organizations are changing their culture and decision-making to meet sustainability targets.” Clients and CBRE professionals attended the virtual event, where experts shared best practices and solutions to identify and establish strategies to meet sustainability goals.
-
As life sciences firms vie for scarce research talent, explore top and emerging markets, salary and cost trends and more.
-
Brief | Intelligent Investment
Despite the Cost, Construction of Life Sciences Properties Brings Strong Returns
April 21, 2022
Although a costly proposition, investors are realizing strong returns on newly built life sciences properties or those that are converted from other uses.
